Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]

Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]

Chamcheu JC, Siddiqui IA, Adhami VM, et al. Int J Nanomedicine. 2018;13:4189–4206. An error during the preparation of Figures 1 and 5 for publishing led to the inadvertent creation of duplicate regions in images from these figures on pages 4194 and 4199, respectively. The journal wishes t...

Full description

Bibliographic Details
Main Authors: Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:International Journal of Nanomedicine
Online Access:https://www.dovepress.com/erratum-chitosan-based-nanoformulated-epigallocatechin-3-gallate-egcg--peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/erratum-chitosan-based-nanoformulated-epigallocatechin-3-gallate-egcg--peer-reviewed-fulltext-article-IJN

Similar Items